Directly related to this study on cancer-resistance of Spalax are the tumor suppressor p53 favoring cell cycle arrest over apoptosis [24] and a unique Spalax heparanase splice variant that was shown to significantly decrease tumor size and metastatic activity compared to native heparanase [9]. This evidence concerns the gene HPSE and cancer.